Methyl aminolevulinate clinical trials
Also written Metvix.
Includes 2 studies of Methyl aminolevulinate hydrochloride.
How each study uses methyl aminolevulinate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 27 Jul 2004 · METVIXIA · NDA 021415 (FDA, Drugs@FDA; as methyl aminolevulinate hydrochloride)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 11
Galderma R&D (5) · Maastricht University Medical Center (2) · Biofrontera Bioscience GmbH (2) · Joint Authority for Päijät-Häme Social and Health Care (2) · Norwegian University of Science and Technology (1) · Centre Hospitalier Universitaire de Nīmes (1) · Fundación Dermabase (1) · Innovaderm Research Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses methyl aminolevulinate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 18
- Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's DiseaseCompletedPhase 4Maastricht University Medical CenterNCT03909646Written as Methyl Aminolevulinate (Mal) for Topical Administration, 16.8%, 1 GramHow we know
- Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell CarcinomaCompletedPhase 3Galderma R&DNCT00469417Written as Metvix® creamHow we know
- Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell CarcinomaCompletedPhase 3Galderma R&DNCT00472108Written as Metvix creamHow we know
- Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged SkinCompletedPhase 2Galderma R&DNCT00437320Written as Metvix Cream 160 mg/gHow we know
- Metvix PDT in Participant With "High Risk" Basal Cell CarcinomaCompletedPhase 3Galderma R&DNCT00473343Written as Metvix® creamHow we know
- Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic TherapyCompletedPhase 3Biofrontera Bioscience GmbHNCT02144077Written as methyl-aminolevulinateHow we know
- PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AKCompletedPhase 4Galderma R&DNCT03511326Written as Methyl Aminolaevulinate 16% CreamHow we know
- Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)CompletedPhase 4Joint Authority for Päijät-Häme Social and Health CareNCT02464709Written as Methyl 5-aminolevulinateHow we know
- New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)CompletedNot applicableNorwegian University of Science and TechnologyNCT01482104Written as MAL-PDT re-treatmentHow we know
- Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic TherapyCompletedPhase 3Biofrontera Bioscience GmbHNCT02799069Written as MAL CreamHow we know
- Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field CancerizationStatus unknownNot applicableUniversity of Sao Paulo General HospitalNCT03013647Written as Methyl AminolevulinateHow we know
- Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)CompletedPhase 4Joint Authority for Päijät-Häme Social and Health CareNCT01893203Written as MAL creamHow we know
- Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic WoundsCompletedNot applicableCentre Hospitalier Universitaire de NīmesNCT02392390Written as Metvixia creamHow we know
- Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA GelStatus unknownPhase 4Fundación Instituto Valenciano de OncologíaNCT02647151Written as METHYLAMINOLEVULINATE HYDROCHLORIDEHow we know
- Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial PhotodamageCompletedPhase 2Fundación DermabaseNCT02139618Written as Methyl Aminolevulinate (MAL)How we know
- Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage MethylaminolevulinateStatus unknownPhase 4Maastricht University Medical CenterNCT01491711Written as Methylaminolevulinate PDT in 2 sessionsHow we know
- Short Incubation Methylaminolevulinate Photodynamic Therapy Without OcclusionCompletedPhase 3Innovaderm Research Inc.NCT00926952Written as Methylaminolevulinate (Metvix, Metvixia)How we know
- Trial of Methyl Aminolevulinate Plus Aktilite in Facial PhotodamageCompletedPhase 3Universidad de AntioquiaNCT00629317Written as Methyl AminolevulinateHow we know
Given beside what is tested · 5 — methyl aminolevulinate is usual care or a partner of the new treatment
- Actinic Keratoses Treatment With Metvix® in Combination With LightCompletedPhase 3University Hospital, LimogesNCT02373371Written as Metvix®How we know
- New Treatments for Actinic Keratoses of the ScalpActive, not recruitingNot applicableHelsinki University Central HospitalNCT05456334Written as Metvix creamHow we know
- Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled TrialCompletedNot applicableUniversity Hospital, GhentNCT03012009Written as MALHow we know
- Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin CancerCompletedPhase 1Roswell Park Cancer InstituteNCT01292668Written as methyl-5-aminolevulinate hydrochloride creamHow we know
- A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.CompletedPhase 1/2PhotocureNCT00369018Written as methyl aminolevulinate (MAL) and hexaminolevulinate (HAL)How we know
As the comparator · 2 — what is tested is compared with methyl aminolevulinate
- Comparison of Mechanical Penetration Enhancers on Metvixia Skin PenetrationCompletedPhase 1Galderma R&DNCT02511145Written as METVIXIA CreamHow we know
- Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MALActive, not recruitingPhase 1/2Joint Authority for Päijät-Häme Social and Health CareNCT02367547Written as Methylaminolevulinate creamHow we know
Codes
What other systems call methyl aminolevulinate · ClinicalTrials.gg INT004537
- MeSH (NLM) C475457methyl 5-aminolevulinateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 585NM85KYMMETHYL AMINOLEVULINATEConfirmed FDA, NLM, Wikidata
- RxNorm 337068Confirmed FDA, Wikidata
- Wikidata Q619603methyl aminolevulinateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76305Methyl AminolevulinateOne source FDA
- DrugBank DB00992One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C475457 | methyl 5-aminolevulinate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 585NM85KYM | METHYL AMINOLEVULINATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 337068 | — | Confirmed FDA, Wikidata |
| Wikidata | Q619603 | methyl aminolevulinate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76305 | Methyl Aminolevulinate | One source FDA |
| DrugBank | DB00992 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.